Vivinex Impress XY1-EM vs RayOne EMV — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Vivinex Impress XY1-EM vs RayOne EMV — Stella

Recruiting

Back to Cataract trials

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(1 site)

Poland

Medical University of Bialystok, Bialystok, Polska

Key details

Sponsor

Medical University of Bialystok

Enrollment target

~100 participants

Started

January 2026

Primary completion

June 2027

Age range

21 Years – 80 Years

Last updated January 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov